Centro de Investigación en Genética y Genómica (CIGGUR)

Medicina y ciencias biológicas

1. Primary Ovarian Insufficiency 100%
2. Mutation 89%
3. Genes 73%
4. Exome 42%
5. Colombia 38%
6. Whole Exome Sequencing 38%
7. High-Throughput Nucleotide Sequencing 37%
8. Phenotype 35%
9. Vitamin B Complex 32%
10. Pharmacogenetics 29%
11. Attention Deficit Disorder with Hyperactivity 29%
12. Genome-Wide Association Study 23%
13. Drug-Related Side Effects and Adverse Reactions 21%
14. Population 21%
15. Missense Mutation 20%
16. Computational Biology 20%
17. Quantitative Trait Loci 19%
18. Vitamin B 12 19%
19. Habitual Abortion 18%
20. Pre-Eclampsia 18%
21. Thiamine 18%
22. Genomics 17%
23. Pregnancy 15%
24. Exons 15%
25. Warfarin 15%
26. Pyridoxine 15%
27. Meta-Analysis 15%
28. Peripheral Nervous System Diseases 15%
29. Genetic Association Studies 14%
30. Fabry Disease 14%
31. Ebstein Anomaly 14%
32. Pharmaceutical Preparations 14%
33. Alleles 13%
34. Transcription Factors 13%
35. cyanocobalamin, pyridoxine, thiamine drug combination 13%
36. Proteins 13%
37. Apraxias 13%
38. Therapeutics 13%
39. Stevens-Johnson Syndrome 12%
40. Duchenne Muscular Dystrophy 12%
41. Single Nucleotide Polymorphism 12%
42. Gene Frequency 12%
43. Dystrophin 11%
44. Long QT Syndrome 11%
45. Neurobiology 11%
46. Spontaneous Abortion 11%
47. Electrocardiography 11%
48. Ataxia 10%
49. Forkhead Transcription Factors 10%
50. Nervous System 10%
51. Pharmacogenomic Testing 10%
52. Cardiomegaly 10%
53. Cytochrome P-450 CYP2C9 10%
54. Clopidogrel 10%
55. Familial premature ovarian failure 10%
56. Vitamin B 6 10%
57. Pain 9%
58. Medical Students 9%
59. Genome 9%
60. Lupus Coagulation Inhibitor 9%
61. Point Mutation 9%
62. Pathology 9%
63. Ceroid Lipofuscinosis, Neuronal, 6 9%
64. Names 9%
65. Ichthyosis 9%
66. Sequence Analysis 9%
67. Eye 9%
68. SARS Virus 9%
69. Infertility 8%
70. origen 8%
71. Kounis Syndrome 8%
72. Channelopathies 8%
73. Fucosidosis 8%
74. Congenital Pain Insensitivity 8%
75. Self Medication 8%
76. LEOPARD Syndrome 8%
77. RNA Splice Sites 8%
78. Primary Hypertrophic Osteoarthropathy 8%
79. Pandemics 8%
80. Non-Receptor Type 11 Protein Tyrosine Phosphatase 8%
81. Costs and Cost Analysis 8%
82. Biomarkers 8%
83. X Chromosome 8%
84. MutS Proteins 7%
85. Mammalian Chromosomes 7%
86. Colorectal Neoplasms 7%
87. Pharmacogenomic Variants 7%
88. Genetic Profile 7%
89. Chromosomes, Human, X 7%
90. Reproductive Medicine 7%
91. Genetic Counseling 7%
92. 46,XY Disorders of Sex Development 7%
93. Acute Coronary Syndrome 7%
94. placental alkaline phosphatase 7%
95. Steroid 21-Hydroxylase 7%
96. Nonsense Codon 7%
97. HELLP Syndrome 7%
98. Child 7%
99. Hemophilia A 7%
100. Pharmacovigilance 7%